BioLineRx Ltd.

Proxy Solicitation & Information Statement • Aug 20, 2020

Exhibit 2

-BIOLINERX LTD.

For the Annual General Meeting of Shareholders to be held on September 24, 2020

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned shareholder of BioLineRx Ltd. (the "Company") hereby appoints Mali Ze'evi and/or Raziel Fried, and each or either of them, the true and lawful attorney, agent and proxy of the undersigned, with full power of substitution, to vote, as designated below, all of the ordinary shares of the Company which the undersigned is entitled in any capacity to vote at the Annual General Meeting of the shareholders of the Company which will be held at the offices of the Company at Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in 7177871, Israel, on September 24, 2020 at 3:00 p.m. (local time), and all adjournments and postponements thereof.

(CONTINUED AND TO BE SIGNED ON REVERSE SIDE)

SEE REVERSE SIDE

ANNUAL GENERAL MEETING OF SHAREHOLDERS OF

BIOLINERX LTD.

September 24, 2020

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS DIRECTED HEREIN. IF NO DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED "FOR" THE PROPOSALS HEREIN.
	Please mark your vote for the following resolutions as in this example ☒
1.	TO RE-ELECT the following nominees to serve as directors of the Company for the coming year until the next annual general meeting of the Company's shareholders or until their respective successors are duly elected:	FOR	AGAINST	ABSTAIN
2.	a.Aharon Schwartz b.Michael Anghel c.B.J. Bormann d.Raphael Hofstein e.Sandra Panem TO APPROVE amendments to the employment terms of Philip Serlin, the Company's Chief Executive Officer, all as described in the Proxy	☐ ☐ ☐ ☐ ☐ FOR ☐	☐ ☐ ☐ ☐ ☐ AGAINST ☐	☐ ☐ ☐ ☐ ☐ ABSTAIN ☐
	Statement. Do you have a "Personal Interest" (as defined in the Proxy Statement) with respect to the subject matter of this proposal? (Please note: if you do not mark either "Yes" or "No" your shares will not be voted on Proposal 2)	Yes ☐	No ☐
3.	TO APPROVE an increase in the Company's registered share capital from NIS 50,000,000 divided into 500,000,000 ordinary shares of a nominal value of NIS 0.10 each to NIS 150,000,000 divided into 1,500,000,000 ordinary shares of a nominal value of NIS 0.10 each, and a corresponding amendment to Article 4.1 of the Company's Articles of Association.	FOR ☐	AGAINST ☐	ABSTAIN ☐	Name: ______ Number of shares:_____ Signature: ____ Date: ________ NOTE: Please mark date and sign exactly as the name(s) appear on this proxy. If the signer is a corporation, please sign the full corporate name by a duly authorized officer. Executors, administrators, trustees, etc. should state their full title or capacity. Joint owners should each sign.
4.	TO RE-APPOINT Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limitedd, as the independent public auditors of the Company for the year ending December 31, 2020 and to authorize the Audit Committee of the Board of Directors to fix the compensation of said auditors in accordance with the scope and nature of their services.	FOR ☐	AGAINST ☐	ABSTAIN ☐